Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02554760 · ClinicalTrials.gov registry record · NA
Bilateral; Flank Study With Crown Cooling Insert
A NA study of Body Fat Disorder, sponsored by Zeltiq Aesthetics.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
- 1
- Study location
NCT02554760: Completed NA study of Body Fat Disorder, sponsored by Zeltiq Aesthetics.
NCT02554760 is a NA study of Body Fat Disorder that has completed, run by Zeltiq Aesthetics. The registered enrollment target is 19 participants, below the 42-participant average among 3 other Body Fat Disorder trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02554760, a NA study of Body Fat Disorder, has completed, sponsored by Zeltiq Aesthetics.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
- 1
- Study location
Study Summary
Evaluate the safety and efficacy of non-invasive subcutaneous fat layer reduction in the flank using an applicator with and without the Crown Cooling Insert.
Primary Outcome
Change in the treated vs. untreated areas will be assessed by observation of changes in surface contour and/or fat volume by an independent photo review of pre-treatment and post-treatment images of the treated areas. Reviewers will be practicing dermatologists or plastic surgeons. All reviewers will be blinded to post-treatment vs. baseline untreated area. The order in which images will be presented will be randomized; for each subject placement of the baseline, pre-treatment image will be rand
Conditions Studied
Interventions
- DEVICE The ZELTIQ CoolSculpting System
Study Locations (1)
California
- Laser and Skin Surgery of Northern California - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2015-09-15 |
| Est. Completion | 2015-12-17 |
| Phase | NA |
What the finished NCT02554760 record still lists
NCT02554760 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 42-participant average among 3 other Body Fat Disorder trials with a reported enrollment target (55% lower).
The record links to 1 condition, with Body Fat Disorder appearing as the primary indexed condition, and to 1 intervention - of which The ZELTIQ CoolSculpting System is the first listed.
NCT02554760 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02554760 about?
NCT02554760 is a clinical study titled "Bilateral; Flank Study With Crown Cooling Insert". Evaluate the safety and efficacy of non-invasive subcutaneous fat layer reduction in the flank using an applicator with and without the Crown Cooling Insert.
What is the current status of trial NCT02554760?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2015-09-15. Estimated completion is 2015-12-17.
What conditions does trial NCT02554760 study?
This clinical trial studies the following conditions: Body Fat Disorder.
What interventions are being tested in trial NCT02554760?
The interventions under investigation include: The ZELTIQ CoolSculpting System (DEVICE).
Who is sponsoring clinical trial NCT02554760?
This trial is sponsored by Zeltiq Aesthetics, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02554760 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Body Fat Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI